Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.3K Buy
15,206
+428
+3% +$651 ﹤0.01% 938
2026
Q1
$26.7K Hold
14,778
0.01% 779
2025
Q4
$19.9K Hold
14,778
﹤0.01% 700
2025
Q3
$24.1K Sell
14,778
-140
-0.9% -$155 0.01% 311
2025
Q2
$14.5K Buy
14,918
+3,197
+27% +$2.65K 0.01% 276
2025
Q1
$8.28K Buy
+11,721
New +$8.11K 0.01% 192

Other funds holding OCGN

Abel Hall LLC's OCGN Position: Q2 2026 in Review

Abel Hall LLC increased its Ocugen (OCGN) stake by 2.9% in Q2 2026, buying an estimated $651 and bringing the position to 15,206 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Abel Hall LLC first reported a position in OCGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $26.7K in Q1 2026. 27 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Abel Hall LLC held 15,206 shares of Ocugen worth $23.3K as of Q2 2026.
  • Abel Hall LLC bought 428 Ocugen shares in Q2 2026, an estimated $651.
  • Ocugen made up ﹤0.01% of Abel Hall LLC's portfolio in Q2 2026, its #938 holding.
  • Abel Hall LLC first reported a position in Ocugen in Q1 2025 and has held it in 6 quarters since.
  • Abel Hall LLC's Ocugen position peaked at $26.7K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.